FDA Inspection 944819 — Grifols Biologicals LLC

Grifols Biologicals LLC — FEI 2080769

The FDA completed an inspection of Grifols Biologicals LLC on October 20, 2015 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 20, 2015
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)